about
Increased prolactin levels are associated with impaired processing speed in subjects with early psychosisChlorpromazine-Induced Hyperprolactinemia on Rat's UterusDetecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysisSexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study.Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents.Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trialsHigh prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injuryProlactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.Osteoporosis and fracture risk in people with schizophreniaEjaculatory dysfunction associated with low dose amisulpride.Management of schizophrenia: clinical experience with asenapine.Pharmacological approaches to the management of schizophrenia: 10 years on.Challenges and pitfalls in the diagnosis of hyperprolactinemia.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study.Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.Pituitary gamma-aminobutyric acid receptor stimulation by carnitine may be a new strategy for antipsychotic-induced hyperprolactinemia.Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China.Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Elderly Antipsychotic-Treated Women With Type 2 Diabetes and Subclinical Hypothyroidism: A Preliminary Study.Clinical Management of Antipsychotic-Induced Hyperprolactinemia.Physical health algorithms for mental health care.ANZJP this month.Attitudes toward menstruation in females with schizophrenia or schizoaffective disorders in Taiwan.Male Reproductive Functions Disrupted by Pharmacological Agents.Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis.
P2860
Q28540093-FD1C20C9-A82B-4618-9D8D-594EDB94ADFAQ28607320-D6C9B6FB-8824-4F53-8645-F4DEC91D144EQ34660087-69995C5E-400A-4A88-9B18-129C1CE63141Q35029078-1D33227A-6756-4668-8781-C8105F4E817DQ35038921-10358C34-8E59-4E50-97FB-46CEBD3248EFQ35214820-7EE9D3ED-0F0A-453E-BB47-C4100ED7F0CBQ35740384-9F2CBBA7-A19B-41AF-A91C-67AEB17A15D6Q36188000-87C6C765-8490-4AB1-ABC9-2F84403AB731Q36592205-7E561B10-839C-4575-8E62-585312551B77Q36615542-4C2AB16D-834C-48C1-A6AC-DD272337B673Q38093729-6B86FD31-BBBB-4B99-8B2B-6EE71897CB9EQ38101540-9B6BBE4A-9B02-4222-8022-F87EE7310BB3Q38204249-EB3C3139-AEAF-46FD-966E-0692A8DABE20Q38815462-76734837-2302-4F53-A6E4-2841BE95FA6AQ47556007-87142734-A155-45E1-AC22-9B36FBCECEEFQ47645310-78C29337-43B9-4B55-8376-28AF9451BCADQ48345162-4E93B55A-CA15-4631-91DC-E4CF9B6772CEQ48397820-099E4219-45FF-40FE-B55C-EBDED4D5D822Q49683655-E685D77D-C9D9-40F2-8EA6-CFDA7A586F94Q50593929-45C9F13A-113E-4122-8651-E16DC2087E06Q50625356-B6981745-C833-42CE-A446-FF6337691323Q50784118-D9630D27-7C94-4D7D-A661-5CC17C283522Q51292022-00B79A5F-E9B9-48C6-8E37-05919B0E95C0Q52687141-81F57DBC-41A1-4684-9FCB-D11ED7DD9568Q54959236-B6FD5596-8840-488A-89C8-F555F4B85BC3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antipsychotic-induced hyperprolactinaemia.
@en
Antipsychotic-induced hyperprolactinaemia.
@nl
type
label
Antipsychotic-induced hyperprolactinaemia.
@en
Antipsychotic-induced hyperprolactinaemia.
@nl
prefLabel
Antipsychotic-induced hyperprolactinaemia.
@en
Antipsychotic-induced hyperprolactinaemia.
@nl
P2860
P1476
Antipsychotic-induced hyperprolactinaemia.
@en
P2093
David Castle
Warrick J Inder
P2860
P304
P356
10.3109/00048674.2011.589044
P577
2011-06-30T00:00:00Z